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Abstract We tested the effect of melatonin on membrane 
fluidity in microsomes of a rat liver model in which lipid 
peroxidation was induced by the addition of FeCl3, ADP and 
NADPH. Membrane fluidity was monitored using fluorescence 
spectroscopy and lipid peroxidation was estimated by quantifying 
malonaldehyde (MDA)+4-hydroxyalkenals (4-HDA) concentra-
tions following the induction of lipid peroxidation with and 
without pre-incubation with melatonin (1 μ Μ - 3 mM). Mem-
brane rigidity increased during induced lipid peroxidation while 
melatonin reduced in a concentration-dependent manner both 
membrane rigidity and MDA+4-HDA generation. Melatonin's 
protective effect may relate to its known ability to scavenge free 
radicals and function as an antioxidant. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Lipid peroxidation is an autooxidative process initiated by 
a variety of free radicals to which polyunsaturated fatty acids 
present in cell membranes are susceptible [1]; the process of 
lipid peroxidation leads to the formation of LOO·, endoper-
oxides and hydroperoxides [2]. Once formed, unstable LOO· 
are able to propagate a chain reaction of the lipid peroxida-
tion process [3]. Associated with these changes in the mem-
brane, several authors claim an increase in phospholipid bi-
layer rigidity after lipid peroxidation [4,5]. The physiological 
importance of modifications in the physical properties of 
membranes resides in their relation to numerous cellular func-
tions, including the activity of membrane-associated enzymes 
solute transport and hormone-induced signal transduction 
processes [2,6]. Both, lipid peroxidation and membrane fluid-
ity have been implicated in disease processes and aging path-
ophysiology [7-9]. Several agents are known to be stabilizers 
or protectors of cell and organelle membranes because of their 
inhibitory effects on lipid peroxidation [5,10]. 
7V-Acetyl-5-methoxytryptamine or melatonin is produced by 
the pineal gland in all vertebrates. This chemical mediator 
modulates a variety of endocrine, neural and immune func-
tions [11,12]. Recently, its direct scavenging action against free 
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Abbreviations: MDA, malonaldehyde; 4-HDA, 4-hydroxyalkenals; 
LOO·, peroxyl radical; -OH, hydroxyl radical; TMA-DPH, l-(4-
trimethylammoniumphenyl)-6-phenyl-l,3,5-hexatriene-p-toluene-sulfo-
nate; THF, tetrahydrofuran 
radicals was reported [13]. Besides its ability to scavenge 
highly reactive radicals, melatonin's antioxidant activity is 
augmented by its ability to stimulate enzymes related to the 
antioxidative defense system [14-17]. In addition, the efficacy 
of melatonin as an antioxidant may relate to the ease with 
which it crosses biological membranes [18]. In this report we 
investigated, utilizing hepatic microsomal membranes, the ef-
fect of melatonin on membrane fluidity that was modulated 
by lipid peroxidation due to F e 3 + / A D P / N A D P H . 
2. Materials and methods 
Melatonin, ADP, ferric chloride, NADPH and EDTA were pur-
chased from Sigma (St. Louis, MO). TMA-DPH was purchased from 
Molecular Probes (Eugene, OR). The Bioxytech LPO-586 kit for lipid 
peroxidation was obtained from Caymen Chemical (Ann Arbor, MI). 
Other chemicals used were of analytical grade and came from com-
mercial sources. Melatonin was diluted in ethanol and water and 
TMA-DPH in THF and water. Ethanol and THF concentrations in 
the incubation volume were 2 and 0.4%, respectively. Other chemicals 
were diluted in the incubation buffer. 
Male Sprague-Dawley rats, weighing 230-250 g, were sacrificed by 
decapitation and the livers were removed quickly, washed in 0.9% 
NaCl (4°C), frozen in liquid nitrogen and stored at —80°C prior to 
use. Pooled microsomes were isolated according Yu et al. [19]. Briefly, 
liver was homogenized 1 : 10 w/v in 140 mM KC1/20 mM HEPES 
buffer (pH 7.4) and the resulting suspension centrifuged at 1000Xg 
for 10 min at 4°C. The supernatant was centrifuged at 105 000Xg for 
60 min at 4°C. The pellet obtained was re-suspended in the buffer and 
centrifuged at lOOOOXg for 15 min at 4°C. The supernatant, which 
contained only microsomal fraction, was centrifuged once at 
105000Xg for 60 min at 4°C. The final pellet was re-suspended 
1 : 1 w/v and kept at — 80°C until assay. 
Microsomes (0.5 mg/ml microsomal protein), suspended in 50 mM 
Tris-HCl buffer (pH 7.4), were incubated at 37°C for 30 min with 
melatonin (3 mM, 1 mM, 300 μΜ, 100 μΜ, 10 μΜ or 1 μΜ). Lipid 
peroxidation was induced in the membrane samples by adding FeCf¡ 
(0.2 mM), ADP (1.7 mM), NADPH (0.2 mM) and the incubation was 
carried out at 37°C for 20 min with shaking. The reaction was stopped 
by adding EDTA (2 mM). Kinetic studies were performed to deter-
mine the optimal incubation times. Control microsomes and those 
with induced lipid peroxidation were treated under the same condi-
tions (incubation and addition of ethanol) as samples treated with 
melatonin. In another study, only microsomes incubated with similar 
concentrations of melatonin and controls were used. Solutions of 
melatonin, FeCl3, ADP and NADPH were prepared fresh just prior 
to use. 
Membrane fluidity and MDA+4-HDA were measured after incu-
bations were complete. Fluidity was studied using the TMA-DPH as 
probe. Its incorporation into microsomal membrane and the determi-
nation of membrane fluidity was done according to the method of Yu 
et al. [19]. Microsomes (0.5 mg protein) were re-suspended in Tris (3 
ml final volume) and incorporated with TMA-DPH (66.7 nM). After 
mixing vigorously on a vortex for 1 min, the preparation was incu-
bated for 30 min at 37°C. Fluorescence measurements were carried in 
a Perkin-Elmer LS-50 Luminescence Spectrometer equipped with a 
circulatory water bath to maintain the temperature of 22±0.1°C. 
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Excitation and emission wavelengths of 360 nm and 430 nm were 
used, respectively. The emission intensity of vertically polarized light 
was detected by an analyzer oriented parallel (Iyv) or perpendicular 
(IvH) to the excitation plane. A correction factor for the optical sys-
tem, G, was used. Polarization (P) and anisotropy (A) were calculated 
by equations 1 and 2, respectively. 
Ivv—GIvH 
Vv ' -GI-■ V H 
■Vv ' -GI v„ 
Iw + 2Gl· VH 
(1) 
(2) 
An inverse relationship exists between membrane fluidity and polar-
ization and anisotropy [19]; thus, membrane fluidity is expressed as 1/ 
P and 1/A, respectively. Membrane fluidity was calculated from trip-
licate determinations. Combined MDA+4-HDA concentrations are 
used as an index of lipid peroxidation of membranes [20]; this was 
measured by a colorimetric assay using the kit mentioned above. 
Results are presented as nmol MDA+4-HDA/mg microsomal protein. 
Protein concentration was determined by the Bradford method [21] 
using bovine serum albumin as standard. 
The data are expressed as arithmetic mean and S.E. values. Mean 
differences were determined using a paired i-test, with a level of sig-
nificance P < 0.05. 
3. Results 
Under the conditions of this study, the addition of FeCl3, 
ADP and NADPH decreased microsomal membrane fluidity, 
quantitated as changes in 1/P and 1/A, and increased 
MDA+4-HDA levels. Pre-incubation of the microsomes 
with melatonin at the concentration of 300 μΜ or greater 
increased significantly (P<0.05) membrane fluidity and re-
duced MDA+4-HDA formation compared to those in the 
non-melatonin-treated samples. Melatonin at 3 mM prevented 
membrane rigidity completely; in this case no significant dif-
ferences in 1/P and 1/A were observed relative to controls. 
Results of 1/P, 1/A and MDA+4-HDA measurements after 
various treatments are summarized in Table 1. The ability 
of melatonin to inhibit membrane fluidity and to decrease 
MDA+4-HDA was dose-dependent. The concentration of 
melatonin required to inhibit MDA+4-HDA formation by 
50% (1.25 mM), i.e. the IC50, was slightly less than that re-
quired to prevent membrane rigidity (1.5 mM). IC50 values 
were calculated from the data presented in Fig. 1. 
In a subsequent experiment, to clarify whether melatonin 
may alter membrane fluidity in the absence of lipid peroxida-
tion, microsomes were incubated with the same concentra-
tions of melatonin used in the initial studies. No significant 
differences in membrane fluidity or MDA+4-HDA levels were 
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Fig. 1. Ability of melatonin to reduce microsomal membrane ri-
gidity and to inhibit lipid peroxidation. (·) 1/Polarization; (■) 
1/Anisotropy; ( A ) MDA + 4-HDA. Melatonin is expressed as a log-
arithm of its molar concentration. 
found between control samples and those incubated with mel-
atonin. Table 2 summarizes these results. 
4. Discussion 
Biophysical measurements of membrane fluidity provide a 
structural alteration of the consequences of lipid peroxidation. 
Lipid peroxidative stress is known to decrease membrane flu-
idity in microsomes [22] and other cellular membranes [23,24]. 
The present results, using TMA-DPH as a fluorescence probe, 
are consistent with these observations. Structural changes in 
the membrane including the loss of polyunsaturated fatty 
acids [2,25] and the formation of cross-linking of lipid—lipid 
and lipid-protein moieties [5,25,26] are known to be the basic 
mechanisms for membrane rigidity. 
In the present studies, when microsomes were incubated 
with different concentrations of melatonin prior to the induc-
tion of lipid peroxidative damage, a reduction in P and A 
parameters, and thus the increase of membrane fluidity was 
observed. A corresponding protective effect of melatonin also 
was observed as indicated by the extent of MDA+4-HDA 
generation. 
Table 1 
The effects of incubation with melatonin prior to induced lipid peroxidation on membrane fluidity (1/P and 1/A) and MDA+4-HDA concentra-
tions 
1/P 1/A MDA+4-HDA (nmol/mg protein) 
Control 
Induced lipid peroxidation 
Induced lipid peroxidation+melatonin 
(3mM) 
(1 mM) 
(300 μΜ) 
(100 μΜ) 
(10 uM) 
(ΙμΜ) 
3.234 ±0.020 
2.796 ±0.016" 
3.256 ±0.016b 
2.926 ±0.020"b 
2.854 ±0.007"b 
2.808 ± 0.010a 
2.776 ±0.009" 
2.798 ±0.009" 
4.330 ±0.028 
3.684 ±0.024" 
4.344 ±0.024b 
3.872 ±0.032ab 
3.754 ±0.024"b 
3.690 ±0.023" 
3.684 ±0.010" 
3.680 ±0.018" 
2.872 ±0.561 
80.380 ±3.237" 
4.274 ±0.498ab 
46.940 ±2.249"b 
67.020 ±3.205"b 
77.140 ± 3.758a 
78.980 ±3.270" 
74.220 ±3.803"b 
Data are expressed as mean ± S.E. values obtained in five independent experiments. 
"Denotes statistical differences (P < 0.05) vs. control and bvs. lipid peroxidation. 
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Table 2 
MDA + 4-HDA concentrations and membrane fluidity, expressed as an inverse of polarization or anisotropy after incubation with melatonin 
1/P 1/A MDA + 4-HDA (nmol/mg protein) 
Control 
Melatonin 
(3 mM) 
(1 mM) 
(300 μΜ) 
(100 μΜ) 
(10 μΜ) 
( Ι μ Μ ) 
3.185±0.018 
3.197 ±0.008 
3.168±0.016 
3.185 ±0.029 
3.152 ±0.020 
3.150±0.011 
3.153±0.017 
4.262 ±0.035 
4.293 ±0.019 
4.235 ±0.021 
4.302 ±0.059 
4.200 ±0.024 
4.225 ±0.010 
4.267 ±0.028 
3.290 ±0302 
3.170±0.365 
3.235 ±0.236 
3.430 ±0.433 
3.370±0.311 
3.385 ±0.355 
3.360±0.312 
Results are mean ± S.E. values obtained in four experiments. 
Initiation and propagation of lipid peroxidation in micro-
somes is a complex chain reaction wherein the ·ΟΗ, LOO· and 
perferryl ion are involved [27] in a process dependent on 
NADPH, ADP, Fe3+ cytochrome P450 [28]. Melatonin's abil-
ity to reduce free radical-mediated damage is documented in a 
variety of investigations in which both in vivo and in vitro 
models of free radical generation were used [29,30]. Its role as 
a scavenger against the highly reactive ·ΟΗ [13], a process that 
involves electron donation [31], and also its efficacy in pre-
venting damage due to the LOO·, have been demonstrated 
[32]. The close relationship between biochemical membrane 
damage, expressed by MDA+4-HDA formation, and the de-
crease in membrane fluidity (Fig. 1), which were both inhib-
ited by melatonin, make likely a scavenging mechanism to 
explain the reduction in membrane rigidity. Moreover, the 
lack of significant changes in polarization and anisotropy in 
the experiment performed to investigate whether melatonin 
would modify membrane fluidity in the absence of lipid per-
oxidation re-inforces the hypotheses that free radical scaveng-
ing may be the underlying mechanism whereby melatonin 
promotes membrane stabilization. 
Other antioxidants also are believed to prevent changes in 
membrane fluidity induced by peroxidative damage by reduc-
ing the generation of free radicals [10,22,23]. Some of them, 
however, only partially reduce the changes or even decreased 
membrane fluidity [33]. 
A particular interest is that melatonin only changed mem-
brane fluidity when it accompanied oxidative stress. This phe-
nomenon may become significant in understanding the effect 
of the reported antiaging action of melatonin. During the 
aging process it is known that membrane rigidity increases 
as a consequence of lipid peroxidation [19]. The present re-
sults indicate that melatonin's action is to stabilize membrane 
fluidity presumably at the optimal level. There are some scav-
engers which decrease membrane fluidity under these circum-
stances [34,35]. 
Evidence to date suggests that melatonin resists oxidative 
stress by scavenging free radicals [13,29-32] and by stimulat-
ing the activity of certain antioxidative enzymes [14-17]. The 
current findings show that stabilizing cell membranes may be 
another important function by which melatonin reduces oxi-
dative damage to cells and organs. Alterations in membrane 
fluidity have major consequences in terms of cellular function 
[6] and, thus, melatonin's ability to stabilize membranes may 
further contribute to the cell protective actions of this mole-
cule [36]. 
In conclusion, these results indicate that melatonin stabil-
izes microsomal membranes and resists the rigidity induced by 
free radical attack. Based on these results and those from 
previous studies [37], it is presumed that melatonin's ability 
to stabilize cellular membranes is a result of its free radical 
scavenging activity and is related to its ability to reduce lipid 
peroxidation. 
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